Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Exedy Corporation | 64M | Nov 21, 2024 | 25.20 | 0.00 |
EXEL COMPOSITES OYJ | 8TY | Nov 21, 2024 | 0.27 | -1.12 |
Exel Industries | 8YK | Nov 21, 2024 | 45.70 | +0.66 |
Exelixis, Inc. | EX9 | Nov 21, 2024 | 32.49 | -0.09 |
Exelon Corporation | PEO | Nov 21, 2024 | 36.57 | -0.46 |
ExlService Holdings, Inc. | LHV | Nov 21, 2024 | 41.73 | -1.16 |
Exmar NV | 1EX | Nov 21, 2024 | 8.06 | +2.41 |
Exor N.V. | EYX | Nov 21, 2024 | 93.40 | -1.06 |
EXOSENS EO -,425 | H8Y | Nov 21, 2024 | 19.34 | +1.68 |
eXp World Holdings, Inc. | 44Y | Nov 21, 2024 | 12.09 | +0.29 |
Expedia Group, Inc. | E3X1 | Nov 21, 2024 | 173.80 | +4.52 |
Expeditors International of Washington, Inc. | EW1 | Nov 21, 2024 | 111.60 | +1.13 |
Experian PLC | J2B | Nov 21, 2024 | 43.80 | 0.00 |
Experian Plc | J2BA | Nov 21, 2024 | 43.60 | -0.91 |
EXPERT SYSTEM S P A AZIONI ORDINARIE SENZA VALORE (NOMINALE | 3K2 | Nov 21, 2024 | 1.38 | -1.29 |
Exploits Discovery Corp | 634 | Nov 21, 2024 | 0.03 | -0.72 |
Exponent, Inc. | EP5 | Nov 21, 2024 | 91.20 | +1.54 |
ExpreS2ion Biotech Holding | 5JD0 | Nov 21, 2024 | 1.79 | 0.00 |
ExpreS2ion Biotech Holding | 5JD | Nov 21, 2024 | 0.07 | 0.00 |
Exro Technologies Inc | 1O2 | Nov 21, 2024 | 0.11 | -15.38 |
Exsitec | 1TI | Nov 21, 2024 | 12.30 | +2.50 |
Extendicare Inc | 5XE | Nov 21, 2024 | 6.75 | +1.50 |
Extra Space Storage Inc. | FG8 | Nov 21, 2024 | 158.95 | +1.70 |
Extreme Networks, Inc. | EXM | Nov 21, 2024 | 14.47 | +0.80 |
Exxaro Resources Ltd | LCQ | Nov 21, 2024 | 8.70 | +2.35 |
EXXON MOBIL CDR REG.S | XON | Nov 21, 2024 | 15.01 | 0.00 |
Exxon Mobil Corporation | XONA | Nov 21, 2024 | 116.28 | +2.18 |
EyePoint Pharmaceuticals, Inc. | PV3B | Nov 21, 2024 | 8.45 | -2.47 |
Ezaki Glico Co. Ltd. | 5EJ | Nov 21, 2024 | 26.00 | -0.76 |
EZCORP, Inc. - Class A Non-Voting | EZ2A | Nov 21, 2024 | 11.40 | +0.89 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.